• 검색 결과가 없습니다.

Thrombolytic Treatment for Acute Ischemic Cerebral Stroke: Intraarterial Urokinase Infusion vs. Intravenous Heparin and Urokinase Infusion

N/A
N/A
Protected

Academic year: 2021

Share "Thrombolytic Treatment for Acute Ischemic Cerebral Stroke: Intraarterial Urokinase Infusion vs. Intravenous Heparin and Urokinase Infusion"

Copied!
12
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Fig.  3.  Filty-eight-year-old  man  wi th  4- 4-hour  duration  01  progressive  brain  stem  dyslunction
Fig.  4.  Fifty-nine-year-old  man  with  6  hour  duration  01  right  hemiparesis  and  lacial  palsy
Fig.  6.  Sixty-three-year-이 d  woman  with  4-hour  duration  of  right  hemiparesis ,  facial  palsy  and  severe  aphasia
Table 1 .  Patient Characteristics  in  Three  Groups  Parameters  Number  Age(mean , year)  Sex(M/ F)  Inlerval( Hr)  Occlusion  Distal  ICA  MCA-M1  -M2  ACA  VBA  Intravenous urokinase Intravenous heparin Intraarterial urokinase  임상결과 동맥 내  유로키  나제 치료군에
+3

참조

관련 문서

Comparison of clinical risk factors and distribution of age, sex of patients aged ≧80 years and <80 years... Comparison of the stroke subtype and thrombolysis of

Prevalence of sleep-disordered breathing in acute ischemic stroke as determined using a portable sleep apnea monitoring device in Korean subjects.. Obstructive

"Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke

In addition, if the patients had a high MPV level (cut-off value of 7.95 fL) without low-dose aspirin therapy, they were at risk for ischemic stroke, especially in

(C-D) The hip anterioposterior and lateral radiograph shows bone ingrowth without subsidence or osteolysis after 62 months follow up after

Utility of T1-and T2-weighted high-resolution vessel wall imaging for the diagnosis and follow up of isolated posterior inferior cerebellar artery dissection with

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third

Approved clinical use of bone marrow stem cells for myocardial infarction treatment... Cardiac